Aldersberg, et al., “Redistribution and Elimination of Intravenously Injected Particles in Mice”, J. Reticuloendothelial Soc., 6, 536-560 (1969). |
Singer, et al., “Radiolabeled Latex Particles in the Investigation of Phogocytosis in Vivo: Clearance Curves and Histological Observations”, J. Reticuloendothelial Soc., 6, 561-589 (1969). |
Goldstein, et al., “Contrast Media for Magnetic Resonance Imaging”, Ch. 28, Annual Reports in Medicinal Chemistry-24, Academic Press, 1989. |
Tart, et al., “Enteric MRI Contrast Agents: Comparative Study of Five Potential Agents in Humans”, Magnetic Resonance Imaging, vol. 9, pp. 559-568, 1991. |
Wang, et al., “A Kinetic Investigation of the Lanthanide DOTA Chelates. Stability and Rates of Formation and of Dissociation of a Macrocylic Gadolinium II) Polyaza Polycarboxylic MRI Contract Agent”, Inorg. Chem., 1991, 31, 1095-1099. |
Braybrook, et al., “Synthesis and evaluation of paramagnetic particulates as contract agents for magnetic resonance imaging (MRI)”, Polym. Int. 1991, 26,251-9. |
Aime, et al., “Trends in NMR Studies of Paramagnetic Gd(III) Complexes as Potential Contrast Agents in MRI”. Mag. Res. Imag., vol. 9, 843-847, 1991. |
King, et al., “Paramagnetic Oil Emulsions as Oral Magnetic Resonance Imaging Contrast Agents”, Mag. Res. Imag., vol. 8, 589-598, 1990. |
Chang, “Lanthanide magnetic resonance imaging contrast agents: thermodynamic, kinetic, and structural properties of lanthanide (III) macrocyclic complexes”, Eur. J. Solid State Inorg. Chem. 28, 1991, 237-244. |
Meldru, et al., “Magnetoferritin: In Vitro Synthesis of a Novel Magnetic Protein”, Science, vol. 257, Jul. 24, 1992, 522-523. |
Jurisson, et al., “Coordination Compounds in Nuclear Medicine”, Chem. Rev., 1993, 93, 1137-1156. |
Spirlet, et al., “The gadolinium (III) chelate of 1-oxa-4,7,10-triazacyclododecane-4,7,10-triacectic acid. Formation of polymeric chains in the solid state and relaxivity properties”, J. Chem. Soc., Dalton Trans . . . , 1997, 497-500. |